{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:37:54Z","timestamp":1777603074347,"version":"3.51.4"},"reference-count":38,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID)","award":["R01AI141790"],"award-info":[{"award-number":["R01AI141790"]}]},{"name":"Start-up funds from College of Veterinary Medicine","award":["R01AI141790"],"award-info":[{"award-number":["R01AI141790"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>GW4869, a cell-permeable, selective inhibitor of neutral sphingomyelinase is a pharmacological agent that blocks the production and release of extracellular vesicles (EVs). Our previous studies have shown that GW4869 inhibits flaviviral loads in tick, mosquito and mammalian cells, including murine cortical neurons. Yet the mechanism(s) of GW4869 inhibitor upon viral infections were not addressed. In the current study, we focused on how GW4869 interferes with Langat Virus (LGTV, a tick-borne flavivirus) replication in ISE6 tick cells. First, we found that GW4869 is neither cytotoxic at tested doses of 50, 100, and 150 \u00b5M in tick cells, nor does it directly bind to the free LGTV present in cell culture supernatants. When tick cells were treated with GW4869, followed by infection with viral stock at dilutions of 10\u22122, 10\u22123, 10\u22124 (the infectious dose determination by viral dilution assay), it affected LGTV replication in tick cells. A reduction in viral burden was noted in GW4869-treated tick cells, which constituted more than half the amount of decrease when compared to the mock control. Next, GW4869 treatment not only resulted in decreased LGTV transcript levels in tick cells and EVs derived from these infected cells, but also revealed diminished EVs concentrations. Enhanced IsSMase transcripts in the LGTV-infected group was noted upon GW4869 treatment, thus suggesting a host response to perhaps inhibit virus replication. In addition, GW4869 treatment reduced LGTV loads in density gradient EVs fractions, which correlated with decreased EVs concentration in those fractions. These data not only indicate that GW4869 affects LGTV replication, but that it also interferes with EV secretion and release from tick cells. Lastly, we found that GW4869 inhibits LGTV replication in tick cells but does not directly affect the infectivity of LGTV viral particles. Overall, our study suggests that GW4869 is a potential therapeutic inhibitor in controlling tick-borne diseases.<\/jats:p>","DOI":"10.3390\/v17070969","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:19:31Z","timestamp":1752247171000},"page":"969","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacological Agent GW4869 Inhibits Tick-Borne Langat Virus Replication to Affect Extracellular Vesicles Secretion"],"prefix":"10.3390","volume":"17","author":[{"given":"Md","family":"Bayzid","sequence":"first","affiliation":[{"name":"Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Bhowmick","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Neelakanta","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hameeda","family":"Sultana","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.bbadis.2015.08.010","article-title":"Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction","volume":"1852","author":"Essandoh","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41421-018-0017-2","article-title":"Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869","volume":"4","author":"Huang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe\u2212\/\u2212 Mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Regmi, P., Khanal, S., Neelakanta, G., and Sultana, H. (2020). Tick-Borne Flavivirus Inhibits Sphingomyelinase (IsSMase), a Venomous Spider Ortholog to Increase Sphingomyelin Lipid Levels for Its Survival in Ixodes scapularis Ticks. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00244"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111301","DOI":"10.1016\/j.intimp.2023.111301","article-title":"Inhibition of circulating exosomes release with GW4869 mitigates severe acute pancreatitis-stimulated intestinal barrier damage through suppressing NLRP3 inflammasome-mediated pyroptosis","volume":"126","author":"Shao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110391","DOI":"10.1016\/j.isci.2024.110391","article-title":"GW4869 inhibitor affects vector competence and tick-borne flavivirus acquisition and transmission by blocking exosome secretion","volume":"27","author":"Sultana","year":"2024","journal-title":"iScience"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E6604","DOI":"10.1073\/pnas.1720125115","article-title":"Arthropod EVs mediate dengue virus transmission through interaction with a tetraspanin domain containing glycoprotein Tsp29Fb","volume":"115","author":"Vora","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhou, W., Woodson, M., Neupane, B., Bai, F., Sherman, M.B., Choi, K.H., Neelakanta, G., and Sultana, H. (2018). Exosomes serve as novel modes of tick-borne flavivirus transmission from arthropod to human cells and facilitates dissemination of viral RNA and proteins to the vertebrate neuronal cells. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006764"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/22221751.2019.1578188","article-title":"Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons","volume":"8","author":"Zhou","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","article-title":"The ins-and-outs of exosome biogenesis, secretion, and internalization","volume":"34","author":"Arya","year":"2024","journal-title":"Trends Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","article-title":"Exosome biogenesis: Machinery, regulation, and therapeutic implications in cancer","volume":"21","author":"Han","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kazimirova, M., and Stibraniova, I. (2013). Tick salivary compounds: Their role in modulation of host defences and pathogen transmission. Front. Cell Infect. Microbiol., 3.","DOI":"10.3389\/fcimb.2013.00043"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kazimirova, M., Thangamani, S., Bartikova, P., Hermance, M., Holikova, V., Stibraniova, I., and Nuttall, P.A. (2017). Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface. Front. Cell Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00339"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Labuda, M., Trimnell, A.R., Lickova, M., Kazimirova, M., Davies, G.M., Lissina, O., Hails, R.S., and Nuttall, P.A. (2006). An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020027"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00005-014-0324-8","article-title":"Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases","volume":"63","author":"Neelakanta","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Neelakanta, G., and Sultana, H. (2021). Tick Saliva and Salivary Glands: What Do We Know So Far on Their Role in Arthropod Blood Feeding and Pathogen Transmission. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.816547"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00508-019-1500-y","article-title":"Tick saliva and its role in pathogen transmission","volume":"135","author":"Nuttall","year":"2023","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_18","first-page":"381","article-title":"Vector-host interactions in disease transmission","volume":"2","author":"Nuttall","year":"2000","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Vora, A., Taank, V., Dutta, S.M., Anderson, J.F., Fish, D., Sonenshine, D.E., Catravas, J.D., Sultana, H., and Neelakanta, G. (2017). Ticks elicit variable fibrinogenolytic activities upon feeding on hosts with different immune backgrounds. Sci. Rep., 7.","DOI":"10.1038\/srep44593"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhou, W., Tahir, F., Wang, J.C., Woodson, M., Sherman, M.B., Karim, S., Neelakanta, G., and Sultana, H. (2020). Discovery of Exosomes From Tick Saliva and Salivary Glands Reveals Therapeutic Roles for CXCL12 and IL-8 in Wound Healing at the Tick-Human Skin Interface. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00554"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13071-016-1944-0","article-title":"RNAi reveals proteins for metabolism and protein processing associated with Langat virus infection in Ixodes scapularis (black-legged tick) ISE6 cells","volume":"10","author":"Grabowski","year":"2017","journal-title":"Parasit. Vectors"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2307\/3281008","article-title":"Effect of medium supplements on tick cells in culture","volume":"68","author":"Kurtti","year":"1982","journal-title":"J. Parasitol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Khanal, S., Taank, V., Anderson, J.F., Sultana, H., and Neelakanta, G. (2018). Arthropod transcriptional activator protein-1 (AP-1) aids tick-rickettsial pathogen survival in the cold. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-29654-6"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ahmed, W., Neelakanta, G., and Sultana, H. (2021). Tetraspanins as Potential Therapeutic Candidates for Targeting Flaviviruses. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.630571"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ashour, H., Zafrah, H., and Elsayed, M.H. (2025). Approach for extracellular vesicles in renal therapeutics: Involvement of microRNAs. Folia Morphol.","DOI":"10.5603\/fm.103065"},{"key":"ref_26","first-page":"101469","article-title":"Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases","volume":"53","author":"Bhat","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fu, E., Pan, K., and Li, Z. (2024). Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1503830"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.acr.2024.07.001","article-title":"Advancing cancer therapeutics: Integrating scalable 3D cancer models, extracellular vesicles, and omics for enhanced therapy efficacy","volume":"163","author":"Goncalves","year":"2024","journal-title":"Adv. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kawikova, I., Spicka, V., Lai, J.C.K., Askenase, P.W., Wen, L., Kejik, Z., Jakubek, M., Vales, K., and Spaniel, F. (2025). Extracellular vesicles as precision therapeutics for psychiatric conditions: Targeting interactions among neuronal, glial, and immune networks. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1454306"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/s41467-025-59377-y","article-title":"Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors","volume":"16","author":"Liang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70002","DOI":"10.1002\/ctm2.70002","article-title":"Extracellular vesicles as the next-generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics","volume":"14","author":"Liu","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110389","DOI":"10.1016\/j.exer.2025.110389","article-title":"Extracellular vesicles in the eye: From biomarkers and mediators of disease, to potential therapeutics","volume":"255","author":"Mead","year":"2025","journal-title":"Exp. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Milczek-Haduch, D., Zmigrodzka, M., and Witkowska-Pilaszewicz, O. (2025). Extracellular Vesicles in Sport Horses: Potential Biomarkers and Modulators of Exercise Adaptation and Therapeutics. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094359"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1039\/D4NA00393D","article-title":"Extracellular vesicles: From intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics","volume":"7","author":"Mohamed","year":"2025","journal-title":"Nanoscale Adv."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Puagsopa, J., Tongviseskul, N., Jaroentomeechai, T., and Meksiriporn, B. (2025). Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines. Vaccines, 13.","DOI":"10.3390\/vaccines13030285"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.mocell.2025.100216","article-title":"Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics","volume":"48","author":"Qin","year":"2025","journal-title":"Mol. Cells"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e70448","DOI":"10.1111\/jcmm.70448","article-title":"Role of Triple-Negative Breast Cancer-Derived Extracellular Vesicles in Metastasis: Implications for Therapeutics and Biomarker Development","volume":"29","author":"Wan","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zou, X., and Brigstock, D. (2024). Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomedicines, 12.","DOI":"10.3390\/biomedicines12122848"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:44Z","timestamp":1760033264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["v17070969"],"URL":"https:\/\/doi.org\/10.3390\/v17070969","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}